Blog

Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to take its Actiphage® blood test for bovine TB (bTB) and Johne’s Disease through the validation required for international industry acceptance.

Worldwide a quarter of a million children die of tuberculosis (TB) each year, early diagnosis would help to save their lives but most are unable to produce the sample of mucus that is needed for the current test.

Actiphage® is a rapid blood test for the mycobacteria that cause bovine tuberculosis (bovine TB) and Johne’s disease. A new paper published in the journal of Microbial Biotechnology (3 December) describes how PBD Biotech developed the test.

PBD Biotech has been presented the 2019 Royal Dairy Innovation Award for their rapid Actiphage® diagnostic by HRH The Princess Royal at a special ceremony at Buckingham Palace.

Johne’s disease can be reliably detected in the blood of day-old calves for the first time using a new Actiphage® diagnostic system, it has been revealed by a UK-French team at the European Association of Veterinary Laboratory Diagnosticians (EAVLD) Congress...

Actiphage®, the new highly sensitive and specific blood test for bovine TB, has been accepted for exceptional private use in England, according to a recently published Animal and Plant Health Agency (APHA) protocol.

A new highly sensitive test has found 10 per cent of milk samples contain low levels of the pathogen, according to research due to published in Food Microbiology.